News – Page 7 – Endpoints News

Formation Bio’s up to €545M licensing deal with Sanofi; Otsuka, Harbour BioMed team up

3 weeks ago

Cidara nearly doubles in value as antiviral biologic prevents flu in mid-stage trial

3 weeks ago

Acting CDER chief is leaving after almost nine years at FDA

3 weeks ago

Lilly’s bimagrumab boosts weight and fat loss when added to Novo's Wegovy

3 weeks ago

Illumina to buy SomaLogic for $350M upfront, pushing further into proteomics

3 weeks ago

Updated: Compass claims Phase 3 win in depression for psilocybin drug, yet stock plummets

3 weeks ago

Updated: A puzzling update from Novo Nordisk and new data from Roche at #ADA25

3 weeks ago

FDA unveils new pilot program; Sage finds a buyer; Eli Lilly to acquire Verve; and more

3 weeks ago

Vertex's diabetes cell therapy allows 10 patients to come off insulin

3 weeks ago

CHMP recommends five new drugs, reconsiders Eli Lilly’s Kisunla

3 weeks ago

Inside the FDA’s ‘listening’ tour: Officials agree US lags behind China on drug development

3 weeks ago

Pharma companies are weighing how a drug’s IP location could impact tariffs

3 weeks ago

UK's NICE says Lilly, Eisai's Alzheimer's drugs aren't worth national coverage

3 weeks ago

Early-stage investor Syncona readjusts priorities due to bleak biotech market

3 weeks ago

FDA OKs new label expansions for Dupixent and Incyte's Monjuvi

3 weeks ago

Enzene, Veranova separately unveil expansions; Lotte's new ADC client

3 weeks ago

Roche's venture arm chief to step down in 2026; AstraZeneca obesity leader has retired

3 weeks ago

FDA's top cell and gene therapy leaders exit agency in ongoing CBER changes

3 weeks ago

Grail shares jump on study results for cancer test

3 weeks ago

Gilead gets groundbreaking FDA approval for twice-yearly HIV prevention shot

3 weeks ago

Compounders lose case over semaglutide shortage

3 weeks ago

Zealand study shows higher GLP-1/GLP-2 doses may lead to greater weight loss

3 weeks ago

CBER head Prasad adds chief medical and scientific officer to his title

3 weeks ago

Q&A: New BIO chair to steer industry through ‘existential threats’ despite FDA receptivity

3 weeks ago

First page Previous page 4 5 678 9 10 Next page Last page